Article Details

COVID-19: DCGI clears India's indigenous mRNA vaccine for phase 2/3 clinical trials

Retrieved on: 2021-08-24 15:11:09

Tags for this article:

Click the tags to see associated articles and topics

COVID-19: DCGI clears India's indigenous mRNA vaccine for phase 2/3 clinical trials. View article details on hiswai:

Excerpt

Under India's COVID-19 vaccination expansion strategy, the Drug Controller General of India (DCGI) on Tuesday gave approval to India's first mRNA based ...

Article found on: www.republicworld.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up